|
English

Pr N. Rioux Leclercq
University Professor and Hospital Practitioner in Pathology
Rennes, France
Summary
Years of experience : 20
Number of cases processed per year : > 2000
Publications : 215
WHO publications :
“Classification of Tumours of the Urinary System and Male Genital Organs”
Fourth Edition - 2016
Networks :
CARARE, Coordinator
Diplomas
2003
Graduate of Research Management
2002
InterUniversitary Diploma in Kidney Pathology
2002
PhD in Biology and Medical Science
1997
Msc in Molecular and Cellular Biology
1996
MD in Anatomic Pathology
1996
Board certification in Pathology
1994
Msc in Biology and Medicine
Career path
2008 - Today
University Professor and Hospital Practitioner in Pathology
Pontchaillou Public Hospital, Rennes, France
2006 - 2008
University Lecturer and Hospital Practitioner in Pathology
Pontchaillou Public Hospital, Rennes, France
2000 - 2001
Fellowship
The Johns Hopkins Hospital, Baltimore, USA
Advantages of referring cases to Pr N. Rioux Leclercq

Pr N Rioux-Leclercq is the referring pathologist for kidney tumors in France and is the coordinator pathologist of the French network for a second opinion of rare kidney cancers in adults (Carare, INCa).

She has an experience in Urological Pathology of more than 15 years, and a recruitment of more than 1000 cases per year with emphasis on kidney and prostate disease.
She did a fellowship in urological pathology at the Johns Hopkins Hospital, USA (2000, 2001, Pr JI Epstein).
Since 2008, she has been the Director of the Pathology Department at the Rennes Public Hospital, France. She has a kidney cancer research team and supervise PhDs on kidney cancer every 2 to 3 years with more than 200 publications in urological pathology and more particularly on kidney cancer.
She is the principal investigator (PI) for pathology of several research projects on kidney cancer (Axipap, Strac, Nivoren…).
She is also in charge of a postgraduate education on kidney cancer (International Academy of Pathology/AIP, French section).
She is a member of the International Society of Urologic Pathology (ISUP), the Genitourinary Pathology Society GUPS (in coming), the French Cancer Committee of the French Association of Urology (CCAFU, expert for the kidney cancer pathology).
She is a coauthor for the 2016 WHO classification of tumors of the urinary system and male genital organs (for kidney cancers), and for the european guidelines of renal cell carcinomas.

Rennes Public Hospital has developed a molecular platform specialized in kidney cancer with FISH analysis using the latest new probes (VHL deletion and mutation, TFE3 and TFEB rearrangement, gains of chromosomes 7 and 17.....), CGH-array, and NGS sequencing